Patent Abstract:
The invention is directed to a uterine artery clamp and the relatively non-invasive treatment procedure utilizing this clamp. The uterine clamp includes a clamping member having a jaw with tissue-contacting surfaces for applying pressure to target tissue and a stabilizing member which is configured to be inserted into the patient&#39;s uterine cervical canal. The clamp may be provided with elongated handles to manually adjust the spacing between the jaw and stabilizer and thereby apply pressure to a uterine artery beneath a bundle of tissue held between the jaw and stabilizer. Uterine clamps embodying features of the invention by be used in procedures for treating uterine disorders such as fibroids, DUB, PPH and the like.

Full Description:
CROSS-REFERENCE TO RELATED APPLICATIONS  
       [0001]    This application is a continuation-in-part of U.S. patent application Ser. No. 10/355,809, entitled “Devices and Methods for Treating Vaginal Delivery PPH”, filed Jan. 30, 2003 which is hereby incorporated by reference in its entirety and from which priority is hereby claimed under 35 U.S.C. § 120. 
     
    
     
       FIELD OF THE INVENTION  
         [0002]    The invention is generally directed to the treatment of uterine disorders by detecting and regulating blood flow through one or both of the patient&#39;s uterine arteries.  
         BACKGROUND OF THE INVENTION  
         [0003]    Hysterectomy (surgical removal of the uterus) is performed on approximately 600,000 women annually in the United States. Hysterectomy is often the therapeutic choice for the treatment of uterine cancer, adenomyosis, menorrhagia, prolapse, dysfunctional uterine bleeding (abnormal menstrual bleeding that has no discrete anatomic explanation such as a tumor or growth), and muscular tumors of the uterus, known as leimyoma or uterine fibroids.  
           [0004]    However, hysterectomy is a drastic treatment, having many undesirable characteristics. Thus, any method which can approximate the therapeutic result of a hysterectomy without removing the uterus would be a significant improvement in this field. Newer treatment methods have been developed for some diseases which may spare these women a hysterectomy.  
           [0005]    In 1995, it was demonstrated that uterine fibroids could be treated without hysterectomy using a non-surgical therapy, specifically comprising bilateral intraluminal occlusion of the uterine arteries (Ravina et al., “Arterial Embolization to Treat Uterine Myomata”, Lancet Sep. 9, 1995; Vol. 346; pp. 671-672, incorporated in its entirety herein). This technique is known as “uterine artery embolization”. In this technique, uterine arteries are accessed via a transvascular route from a common femoral artery into the left and right uterine arteries by means of an intravascular catheter and embolic material, such as small metallic coils, polyvinyl alchohol particulate and the like, is delivered through the catheter to the uterine arteries which quickly become occluded.  
           [0006]    The uterus has a dual (or redundant) blood supply, the primary blood supply being from the bilateral uterine arteries, and the secondary blood supply from the bilateral ovarian arteries. Consequently, when both uterine arteries are occluded, i.e. bilateral vessel occlusion, the uterus and the fibroids contained within the uterus are both deprived of their blood supply. However, as demonstrated by Ravina et al., the ischemic effects on the fibroid is greater than the effect on the uterus. In most instances, the fibroid withers and ceases to cause clinical symptoms.  
           [0007]    However, many physicians do not possess the training or equipment necessary to perform catheter-based uterine artery embolization under radiologic direction. Accordingly, there are substantially fewer uterine artery embolizations performed, worldwide, each year than hysterectomies for symptomatic uterine fibroids.  
           [0008]    Recently, fibroid treatment procedures have been described wherein the uterine arteries are temporarily occluded by an intravaginal device which is non-invasively pressed against the patient&#39;s vaginal fornix and clamped or otherwise pressed against tissue bundle with the patient&#39;s uterine artery being within the bundle. Pressure on the tissue occludes the underlying uterine artery. While these procedures have shown much promise, in many situations the devices described to date do not always allow for accurate placement of the clamping surfaces.  
           [0009]    What is needed, therefore, are devices and methods to detect blood vessels and blood flow in blood vessels, and devices and methods to occlude blood flow in blood vessels such as the uterine arteries that can be used by physicians with limited training and equipment.  
         SUMMARY OF THE INVENTION  
         [0010]    The invention is directed to a relatively non-invasive uterine artery occlusion device and system and the procedure for using the device and system for occluding a female patient&#39;s uterine artery. The instruments and their use may be utilized in the treatment of uterine fibroids, dysfunctional uterine bleeding, post partum hemorrhage and other uterine disorders by reducing or terminating blood flow through a patient&#39;s uterine artery.  
           [0011]    A device embodying features of the invention includes an intrauterine clamp which has a pressure applying or clamping member configured to apply pressure against the exterior of the patient&#39;s uterine cervix or against the patient&#39;s vaginal fornix. The intravaginal clamp also has a stabilizing or positioning member which is configured to be inserted into the patient&#39;s uterine cervix so as to stabilize at least a portion of the interior of the uterine cervix and facilitate the more effective application of pressure by the pressure applying member to the exterior of the cervix or the vaginal fornix to ensure effective occlusion of the patient&#39;s uterine artery. The uterine artery occlusion is temporary, and may be partial or complete.  
           [0012]    One method of occluding a blood vessel comprises clamping the blood vessel effective to compress it so that blood flow through the vessel is reduced, or is abolished. Such clamping of a blood vessel may be direct or may be indirect. Preferably, clamping of a blood vessel effective to compress it is accomplished by applying a non-invasive blood vessel occlusion device to tissue near to a blood vessel (e.g., onto tissue surrounding the vessel). A blood vessel occlusion device may also be applied directly onto a blood vessel effective to compress the blood vessel.  
           [0013]    In one embodiment of the invention, a non-invasive blood vessel occluding device (such as a clamp with a sensor) may be applied to a portion of a vaginal wall to detect and/or locate, and to occlude the uterine arteries. A vaginal clamp embodying features of the invention may used to sense the location of a uterine artery adjacent a vaginal wall, and may be used to compress and occlude a uterine artery adjacent a vaginal wall. The vaginal wall may be distended by an occlusion device so as to more closely approach a uterine artery; such an approach may aided by applying pressure or force to the uterus (e.g., by pulling on the uterine cervix). A uterine cervix may be grasped or pulled by any suitable device or implement, including forceps, suction devices, and other instruments, such as a tenaculum.  
           [0014]    A non-invasive blood vessel occluding device embodying features of the invention may be a non-invasive intravaginal uterine artery occlusion device, comprising a pair of pressure-applying members having opposed tissue-contacting surfaces on distal portions thereof; at least one supporting shaft extending from a proximal extremity of at least one of the pressure-applying members which is configured to adjust the distance between the opposed tissue-contacting surfaces of the pressure-applying members; and at least one blood flow sensing sensor on one of the opposed tissue-contacting surfaces. An embodiment of a non-invasive blood vessel occlusion device embodying features of the invention may have, for example, a handle, a clamping member configured to apply pressure or force to body tissue, and a sensor for locating a blood vessel.  
           [0015]    A pressure-applying member, such as a clamping member, may be, e.g., a jaw or jaws configured to engage a blood vessel or to engage tissue adjacent a blood vessel. A supporting shaft, such as a handle, is preferably configured for manipulating the jaw or jaws. In some embodiments of devices having features of the invention, a pressure-applying member may be attached to a connecting portion that is configured so that a jaw may be placed within a vagina while a handle remains outside a patient&#39;s body and available for use by an operator.  
           [0016]    The clamping member is preferably provided with a blood flow sensor for locating the blood vessel to be occluded. The sensor may sense sound, pressure, strain, stress, chemical entity, electromagnetic radiation and the like, and may be a combination of such sensors. A sensor is preferably a Doppler ultrasound sensor. The sensor is mounted to the face of a tissue-contacting surface of the clamping member, such as the face of a jaw of a clamp, and is preferably oriented perpendicularly to the clamp face, although other orientations may be employed. Ultrasound energy useful for sensing a location of a blood vessel or of blood flow in a blood vessel has a frequency of less than about 20 MegaHertz (MHz), such as between about 5 MHz and about 19 MHz, and preferably between about 6 MHz and about 10 MHz. In commercially available Doppler sensors the frequency is typically about 8 MHz. For sensors based on electromagnetic energy useful for sensing a location of a blood vessel or of blood flow in a blood vessel, the EM energy should have a wavelength of about 500 nanometers (nm) to about 2000 nm, preferably about 700 nm to about 1000 nm.  
           [0017]    A system embodying features of the invention includes an blood vessel occluding device as described above with a blood flow sensor on the clamping member for locating the target blood vessel, and a sensor controller which may include an energy source for the sensor. The sensor controller may be configured to aid in detecting a location of a blood vessel, by, e.g., providing a signal related to the output of a sensor that may be readily used by an operator. A sensor controller may include an energy source configured to provide energy for operating a blood flow sensor.  
           [0018]    A method for occluding a uterine artery which embodies features of the invention include advancing the clamping device through the patient&#39;s vaginal canal, guiding the stabilizing member of the clamping device through the cervical os, into the cervical canal with the clamping member spaced from the stabilizing member so that the pressure applying surfaces of the clamping member is pressed into the patient&#39;s vaginal fornix. Adjustment of the clamping member allows the sensor on the distal end thereof to locate the uterine artery a short distance from the surface of the vaginal fornix. With the clamping member adjacent to the target blood vessel, the clamping device can be closed to compress underlying tissue and thereby occlude the uterine artery. The uterine artery is located with the blood flow sensor on the distal end of the clamping member. Tension may be applied to the uterine cervix with a grasping implement (e.g., by pulling on the uterine cervix) while applying force or pressure to a vaginal wall to occlude a uterine artery.  
           [0019]    The invention allows for the non-surgical location and occlusion of blood vessels such as the uterine artery, providing effective therapeutic treatment. Importantly, the present invention allows for the occlusion of a female patient&#39;s uterine artery without the need for radiographic equipment or for extensive training in the use of radiographic techniques. The devices and methods are simple and readily used for treating uterine fibroids, dysfunctional uterine bleeding (DUB), adenomyosis, post-partum hemorrhage, and other uterine disorders. The devices, systems and methods embodying features of the invention allow for the separate occlusion of individual uterine arteries which provides effective therapy in those situations in which the uterine anatomy will not allow for the use of a single bilateral artery occlusion device.  
           [0020]    These and other advantages will become more apparent from the following detailed description when taken in conjunction with the accompanying exemlary drawings. 
       
    
    
     BRIEF DESCRIPTION OF THE DRAWINGS  
       [0021]    [0021]FIG. 1 is an elevational view of a uterine artery clamping device embodying features of the invention in an open configuration.  
         [0022]    [0022]FIG. 2 is a perspective view of the clamping device shown in FIG. 1.  
         [0023]    [0023]FIG. 3 is an enlarged perspective view of the distal portion of an alternative clamping device having a serrated surface and a plurality of teeth to grasp tissue.  
         [0024]    [0024]FIG. 4 is an enlarged perspective view of an alternative clamping device in which the clamping element and the stabilizer element are provided with teeth to grasp tissue.  
         [0025]    [0025]FIG. 5 is a schematic illustration of the intrauterine clamp in position to occlude a female patient&#39;s uterine artery.  
         [0026]    [0026]FIG. 6 is a perspective view of an alternative embodiment in which the clamping element and the stabilizing element are angled with respect to the handles of the clamp.  
         [0027]    [0027]FIG. 7 is a perspective view of an alternative embodiment in which the spacing between the stabilizing member and the clamping member is adjusted by a spring coil.  
         [0028]    [0028]FIG. 8 is perspective view of an alternative embodiment in which the spacing between the stabilizing member and the clamping member is adjusted by a rack and pinion arrangement. 
     
    
     DETAILED DESCRIPTION OF THE INVENTION  
       [0029]    [0029]FIGS. 1 and 2 show a relatively non-invasive intra-uterine occluding clamp  10  embodying features of the invention. The clamp  10  includes a clamping member  11  having an elongated handle  12  with a finger grip  13 , and pressure-applying clamping element or jaw  14  on the distal end of the clamping element. The intra-uterine clamp also includes stabilizing member  15  which is configured to readily follow or track the patient&#39;s cervical os and cervical canal. The stabilizing member  15  has an elongated handle  16  with a finger grip  17 . The clamping member  11  and stabilizing member  15  are pivotally connected to each other at pivot point  18  and rotation of handles  12  and  16 , preferably by fingers of an operator&#39;s hand engaged through grips  13  and  17  respectively, adjust the spacing between the jaw  14  and the distal portion of stabilizing member  15 . Each of the handles  12  and  16  are provided with a ratchet member  19  and  20  respectively which interact to lock the relative positions of the clamping member  11  and the stabilizing member  15 .  
         [0030]    A uterine artery clamp embodying features of the invention is preferably provided with a blood flow sensor  22 , preferably a Doppler ultrasonic sensing system, on the leading surface of the jaw  14 . This sensor location allows the operator to more easily guide the jaw  14  to the location of the patient&#39;s target uterine artery. Sensor  22  is provided with a signal transmission cable  23  which is operatively connected to sensor control device  24 . Cable  23  may be an insulated wire, plurality of wires, optical fiber, waveguide, or other connection effective to carry signals and/or energy or power between a sensor  22  and sensor controller  24 .  
         [0031]    Sensor  22  may be a blood flow sensor for locating a blood vessel, and may be a passive sensor, configured to detect intrinsic signals indicating the presence of a blood vessel (i.e., a sound sensor, a motion sensor, a pH sensor, or other sensor configured to detect a physical, chemical, electrical, or physiological indication of the location of a blood vessel). In other embodiments, a blood flow sensor for locating a blood vessel may be an active sensor, configured to emit energy or a signal, and configured to detect signals in response to, or derived from, the emitted energy or signal indicating the presence of a blood vessel (i.e., a source of ultrasound having an ultrasound sensor configured to detect ultrasound reflections from a blood vessel, a source of infrared radiation configured to detect reflections from a blood vessel, or other source of energy and a sensor configured to detect a response indicating the location of a blood vessel). The operation of a sensor may be aided by an energy source such as the sensor controller  24 . For example, an energy source may provide electrical energy which aids an ultrasound sensor to produce and to detect ultrasound energy (as, e.g., in the MedaSonics® CardioBeat® Blood Flow Doppler with Integrated Speaker (Cooper Surgical, Inc., Trumbull Conn. 06611)). Other commercially available Doppler ultrasound sensors suitable for use in the present invention include the Koven model ES 100X MiniDop VRP-8 probe (St. Louis, Mo.) and the DWL/Neuro Scan Medical Systems&#39; Multi-Dop B+ system (Sterling, Va.).  
         [0032]    As shown in FIG. 3 jaw  14  may be provided with a serrated, tissue-grasping surface  25  configured to engage and hold onto tissue when jaw  14  is pressed into tissue of the patient&#39;s vaginal fornix. As shown in FIG. 4, one or both of the jaw  14  and/or stabilizer  15  may have retractable fingers or teeth  26  to better secure the contacting members to the target tissue.  
         [0033]    [0033]FIG. 5 illustrates an alternative embodiment wherein the clamping member  11  and the stabilizing member  15  are oriented at an angle θ with respect to the handles  12  and  16 . The angulation provides a more direct attack angle to facilitate insertion of the stabilizing member  15  into the patient&#39;s cervix and direction of the jaw  14  toward a desired location at the patient&#39;s vaginal fornix to facilitate location and occlusion of the patient&#39;s uterine artery. Suitable angulation θ of the jaw  14  and stabilizer  15  is about 100° to about 175°, preferably about 130° to about 160°.  
         [0034]    Closure of a blood vessel, which may be partial or total, is effected by pressure applied through the wall of the patient&#39;s vaginal fornix. Sufficient pressure or force applied to the tissue of the vaginal wall to compress and to at least partially occlude the underlying uterine artery. The blood flow sensor for detecting or locating the uterine artery should be disposed on the leading face off the clamping element and generally perpendicular to the tissue-contacting surface of a jaw  14  to be effective.  
         [0035]    A non-invasive blood vessel occluding device embodying features of the invention may be configured to lock into a clamping position. Such a locked configuration may be temporary and releasable, or may be permanent. Non-invasive blood vessel occluding devices embodying features of the invention may have a locking mechanism, such as a ratchet, configured to hold at least one pressure-applying member in a pressure-applying position. Such locking mechanisms may include a release mechanism effective to allow the cessation of pressure or force application when desired. Thus, a non-invasive blood vessel occlusion device embodying features of the invention may be configured to release a locking mechanism effective to relieve the occlusion of a blood vessel by ending the application of pressure or force that had been previously applied to occlude a blood vessel.  
         [0036]    The uterine arteries in human females are located adjacent the vaginal mucosa at a location within a few centimeters (cm) of the vaginal fornix. As a result, for accessing and occluding a uterine artery from within the patient&#39;s vaginal canala, the dimensions of a vagina determine what size clamping device is suitable, taking into consideration that the clamping device should readily reach the vaginal fornix and be operated from outside of a patient&#39;s body. For example, a clamping device may be between about 5 to about 16 inches in length, preferably between about 6 inch to about 12 inches in length for most applications.  
         [0037]    [0037]FIG. 6 schematically illustrates in part a human female reproductive system, including a uterus  30 , uterine cervix  31 , uterine artery  32 , vaginal canal  33  and vaginal fornix  34 . A method of using the uterine artery clamp embodying features of the invention includes introducing the clamp  10  into the patient&#39;s vaginal canal  33  and advancing the clamp therein until the distal portions of the clamp are adjacent to the patient&#39;s uterine cervix  31 . The position of the handles  12  and  16  are adjusted to increase the spacing between the jaw  14  and the distal portion of the stabilizer  16 . The distal end of the stabilizer is guided through the cervical os  35  into the uterine cervix. The distal end of jaw  14  is urged against the vaginal fornix  34  and  14 . With the guidance of the Doppler sensor  22 , the pressure applying surface of the jaw is positioned as close as possible to the patient&#39;s uterine artery  32 . Sufficient pressure is applied to the uterine artery  32  or the tissue surrounding the uterine artery by jaw  14  to facilitate occlusion of the uterine artery. The handles  12  and  16  are locked by ratchet members  19  and  20  to press the jaw  14  against the tissue between the jaw  14  and the stabilizer  15 . The clamped position is maintained for about 0.5 to about 48 hours, preferably about 1 to about 24 hours for effective therapeutic treatment of a uterine disorder, e.g. for fibroids, PPH, DUB and the like. Blood flow sensor  22  is effective to locate uterine artery  48  by detecting blood flow and monitoring the treatment by detecting the lack of blood flow in the artery. Blood flow in the left uterine artery  50  may be similarly occluded, by a separate uterine artery clamp of the same design or the same clamp can be used on the other side after release of the occlusion of the right uterine artery  34 .  
         [0038]    The ratchet members  19  and  20  are preferably releasable so that clamping member  11  of clamping device  10  can be released after the limited treatment time to re-establish blood flow to the uterine tissue.  
         [0039]    [0039]FIGS. 7 and 8 illustrate alternate clamp design wherein the spacing between the jaw  14  and stabilizer  15  is controlled by a spring  40  as shown in FIG. 7 and a rack and pinion mechanism  50  as shown in FIG. 8. A variety of other means may be employed to open and close the jaw  14  and stabilizer  15 .  
         [0040]    Uterine artery clamp  10  embodying features of the invention may be made from any suitable material or combination of materials, including metals such as stainless steel and superelastic shape memory alloys such as nickel titanium alloys having a stable austenite phase at body temperature, high strength plastics, ceramics, and other materials known in the art. Biocompatible polymers such as polycarbonate, polysulfone, polyester, polyacetal and a variety of fluoropolymers can be suitable for a variety of embodiments of the invention. The device or system may be designed for single use (disposable) or may be sterilizable and capable of multiple use.  
         [0041]    While particular forms of the invention have been illustrated and described, it will be apparent that various modifications can be made to the invention and that individual features shown in one embodiment can be combined with any or all the features of another embodiment described herein. Accordingly, it is not intended that the invention be limited to the specific embodiments illustrated. It is therefore intended that this invention be defined by the scope of the appended claims as broadly as the prior art will permit. Terms such as “element”, “member”, “device”, “sections”, “portion”, “section”, “steps” and words of similar import when used herein shall not be construed as invoking the provisions of 35 U.S.C. § 112(6) unless the following claims expressly use the terms “means” or “step” followed by a particular function without specific structure or action.

Technology Classification (CPC): 0